BACKGROUND Tuberculosis ranks alongside Human Immunodeficiency Virus as a leading cause of death worldwide. 1,2 Psychiatric disorders in chronic medical illnesses have been found to be associated with poor compliance in previous studies. Poor compliance in tuberculosis can have drastic consequences including emergence of drug resistance. 1,2,3,4,5 In this study, we have attempted to study the prevalence of psychiatric disorders in tuberculosis at a tertiary care centre in Chennai. The objectives of the study were-1. To assess the prevalence of psychiatric illnesses in people undergoing treatment for tuberculosis. 2. To assess the association between psychiatric comorbidity and different socio-demographic factors (age, gender, education) and tuberculosis disease related factors. 3. To assess the relationship between psychiatric comorbidity and negative behavioural factors like history of defaulting. MATERIALS AND METHODS Ours is a cross sectional study conducted at the Department of Thoracic Medicine in Government Kilpauk Medical College, Chennai. A total of 106 patients were interviewed and examined. RESULTS We observed that 63.12% of the patients had at least one psychiatric illness. About 62.6% had depressive disorder. Anxiety disorders were found in 23.5%. We also found significant relationships between the following: male gender and presence of psychiatric illnesses, joint family and presence of psychiatric illnesses, dyspnoea grade 3 or more and presence of psychiatric illnesses, dyspnoea grade 3 or more and severity of depression. CONCLUSION The high prevalence of psychiatric disorders in people with tuberculosis warrants specific screening and management.
Background: COVID 19 pandemic and the associated restrictions can have significant impact on patients with pre-existing mental disorders. Fear of getting infected and excessive focus on contamination can worsen in patients with OCD. Methodology: Thirty patients with OCD attending Chengalpattu Medical College Hospital were evaluated for OCD symptom severity using Y-BOCS severity scores in June and July 2020 and that was compared with their scores five months prior (pre covid) Results: Majority of the study population (53%) had no changes in symptom severity after the onset of COVID19 pandemic. Twenty seven percent (27%) had a decrease in symptom severity while only 20% had increase in severity. Conclusion: Our study results indicate that there were no significant changes in OCD symptom severity after the onset of COVID 19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.